(Press-News.org) WASHINGTON, D.C. [September 9, 2025] — Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers devoted to patient care, research, and education—hosted a Policy Summit exploring where artificial intelligence (AI) currently stands as a tool for improving cancer care, and where it may be going in the future. Subject matter experts, including patients and advocates, clinicians, and policymakers, weighed in on where they saw emerging success and also reasons for concern.
Travis Osterman, DO, MS, FAMIA, FASCO, Director of Cancer Clinical Informatics, Vanderbilt-Ingram Cancer Center—a member of the NCCN Digital Oncology Forum—delivered a keynote address, stating: “Because of AI, we are at an inflection point in how technology supports the delivery of care to our patients with cancer. Thoughtful regulation can help us integrate these tools into everyday practice in ways that improve care delivery and support oncology practices. The decisions we make now will determine how AI innovations serve our patients and impact clinicians for years to come.”
Many speakers took a cautiously optimistic tone on AI, rooted in pragmatism.
“AI isn’t the future of cancer care… it’s already here, helping detect disease earlier, guide personalized treatment, and reduce clinical burdens,” said William Walders, Executive Vice President, Chief Digital and Information Officer, The Joint Commission. “To fully realize the promise of AI in oncology, we must implement thoughtful guardrails that not only build trust but actively safeguard patient safety and uphold the highest standards of care. At Joint Commission, our mission is to shape policy and guidance that ensures AI complements, never compromises, the human touch. These guardrails are essential to prevent unintended consequences and to ensure equitable, high-quality outcomes for all.”
Panelists noted the speed at which AI models are evolving. Some compared its potential to previous advances in care, such as the leap from paper to electronic medical records. Many expressed excitement over the possibilities it represents for improving efficiency and helping to support an overburdened oncology workforce and accelerate the pursuit of new cures.
“Artificial intelligence is transforming every industry, and oncology is no exception,” stated Jorge Reis-Filho, MD, PhD, FRCPath, Chief AI and Data Scientist, Oncology R&D, AstraZeneca. “With the advent of multimodal foundation models and agentic AI, there are unique opportunities to propel clinical development, empowering researchers and clinicians with the ability to generate a more holistic understanding of disease biology and develop the next generation of biomarkers to guide decision making.”
“AI has enormous potential to optimize cancer outcomes by making clinical trials accessible to patients regardless of their location and by simplifying complex trial processes for patients and research teams alike. I am looking forward to new approaches for safe evaluation and implementation so that we can effectively and responsibly use AI to gain maximum insight from every piece of patient data and drive progress,” commented Danielle Bitterman, MD, Clinical Lead for Data Science/AI, Mass General Brigham.
She continued: “As AI becomes integrated into clinical practice, stronger collaborations between oncologists and computer scientists will catalyze advances and will be key to directly addressing the most urgent challenges in cancer care.”
Regina Barzilay, PhD, School of Engineering Distinguished Professor for AI and Health, MIT, expressed her concern that adoption may not be moving quickly enough: “AI-driven diagnostics and treatment has potential to transform cancer outcomes. Unfortunately, today, these tools are not utilized enough in patient care. Guidelines could play a critical role in changing this status quo."
She illustrated some specific AI technologies that she believes are ready to be implemented into patient care and asserted her wishes for keeping up with rapidly progressing technology.
Some of the panel participants raised issues about the potential challenges from AI adoption, including:
How to implement quality control, accreditation, and fact-checking in a way that is fair and not burdensome
How to determine appropriate governmental oversight
How medical and technology organizations can work together to best leverage the expertise of both
How to integrate functionality across various platforms
How to avoid increasing disparities and technology gaps
How to account for human error and bias while maintaining the human touch
“Many similar problems have been solved in different application environments,” concluded Allen Rush, PhD, MS, Co-Founder and Board Chairman, Jacqueline Rush Lynch Syndrome Cancer Foundation. “This will take teaming up with non-medical industry experts to find the best tools, fine-tune them, and apply ongoing learning. We need to ask the right questions and match them with the right AI platforms to unlock new possibilities for cancer detection and treatment.”
The topic of AI and cancer care was also featured in a plenary session during the NCCN 2025 Annual Conference. Visit NCCN.org/conference to view that session and others via the NCCN Continuing Education Portal.
Next up, on Tuesday, December 9, 2025, NCCN is hosting a Patient Advocacy Summit on addressing the unique cancer care needs of veterans and first responders. Visit NCCN.org/summits to learn more and register.
# # #
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is marking 30 years as a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
END
MB Mitcham, Director of the Online MPH Program and an Assistant Professor in the Department of Global and Community Health, College of Public Health, received funding for: “Strengthening Food as Medicine Pathways in Southwest Virginia.”
She will serve as the principal investigator and point of contact for George Mason’s subcontract component of this project and will lead George Mason’s efforts by serving as a key member of the Network Planning Group.
The Network Planning Group will come together to determine the next ...
WASHINGTON, D.C. — Every day, millions of Americans face health care decisions — often without the information needed to fully understand the pros and cons of different care options. To help address these evidence gaps, the Patient-Centered Outcomes Research Institute today announced funding awards for patient-centered comparative clinical effectiveness research (CER) studies aimed at improving decision making across a variety of health concerns.
“Patient-centered comparative clinical effectiveness research provides patients and those who care for them with the evidence they need to make more informed health ...
Traditional medicine, encompassing systems such as Ayurveda, Traditional Chinese Medicine (TCM), Kampo, Unani, Siddha, and various indigenous practices, has been a cornerstone of healthcare for centuries. Despite the dominance of modern medicine, T&CM continues to play a vital role in primary healthcare, with approximately 80% of the global population using it at least occasionally. The World Health Organization (WHO) has been instrumental in promoting integration through its Traditional Medicine Strategies (2014–2023 and 2025–2034), urging member states to develop ...
WASHINGTON, Sept. 9, 2025 – Whale watching is a popular pastime on coastlines around the world. Cetaceans like blue whales, humpbacks, and orcas can be seen in the wild, and their characteristics are well categorized in science and popular culture. Other cetaceans, however, are less outgoing, preferring to stay out of the limelight.
Beaked whales are considered one of the least understood mammals in the world, which is due to their cryptic behavior and distribution in offshore waters. Predation pressure from their ...
About The Study: The findings of this study suggest that food insecurity may be an important and modifiable risk factor for long COVID and that strengthening access to programs like Supplemental Nutrition Assistance Program (SNAP), raising awareness, and simplifying enrollment could help reduce the health burden of long COVID.
Corresponding Author: To contact the corresponding author, Jaya Aysola, MD, MPH, email jaysola@upenn.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.30730)
Editor’s ...
About The Study: In this cohort study, bariatric surgery was associated with a significantly lower risk of developing major metabolic comorbidities compared with the medical weight management program. This finding supports the relevance of bariatric surgery as a durable approach for obesity-related risk mitigation.
Corresponding Author: To contact the corresponding author, Amanda L. Bader, MD, email amanda.bader@pennmedicine.upenn.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.30787)
Editor’s Note: Please see the article for additional information, ...
Malnutrition is a leading cause of death in children under age 5, and nearly 150 million children globally under this age have stunted growth from lack of nutrition. Although an inadequate diet is a major contributor, researchers at Washington University School of Medicine in St. Louis found over a decade ago that dysfunctional communities of gut microbes play an important role in triggering malnutrition.
Now, in work done in collaboration with the Salk Institute and UC San Diego, WashU Medicine researchers have discovered that toddlers in Malawi — among the places hardest hit by malnutrition — who had a fluctuating gut microbiome ...
LA JOLLA (September 9, 2025)—Malnutrition is responsible for more than half of all deaths in children under the age of five worldwide. Those who survive can still experience lifelong consequences like cognitive and developmental delays, impaired academic performance, economic instability, and negative maternal health outcomes. This enormous public health issue demands solutions. The latest studies point to gut microbiome—the diverse bacteria, viruses, and other microbes living in our intestines—as a great place to start.
Salk Institute researchers ...
A NIMS research team has developed a magnetic tunnel junction (MTJ) featuring a tunnel barrier made of a high-entropy oxide composed of multiple metallic elements. This MTJ simultaneously demonstrated stronger perpendicular magnetization, a higher tunnel magnetoresistance (TMR) ratio (i.e., the relative change in electrical resistance when the magnetization directions of the two ferromagnetic layers switch between parallel and antiparallel alignments) and lower electrical resistance. These properties may contribute to the development of smaller, higher-capacity and higher-performance hard disk drives (HDDs) and magnetoresistive random ...
“These results support the role of gut microbiome as modulator of the inflammatory and cardiometabolic circuits, that may contribute to the onset of age-related diseases […]”
BUFFALO, NY — September 9, 2025 — A new research paper was published in Volume 17, Issue 8 of Aging-US on August 1, 2025, titled “Causal relationships between gut microbiome and hundreds of age-related traits: evidence of a replicable effect on ApoM protein levels.”
In this study, Federica Grosso, Daniela ...
